Onex Canada Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Onex Canada Asset Management's GILD Position: Q1 2024 in Review
Onex Canada Asset Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 21,935 shares — an estimated $1.78M sold.
Onex Canada Asset Management first reported a position in GILD in Q3 2013 and held it in 24 quarters. The position peaked at $27.8M in Q1 2014. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Onex Canada Asset Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Onex Canada Asset Management sold 21,935 Gilead Sciences shares in Q1 2024, an estimated $1.78M.
- Onex Canada Asset Management first reported a position in Gilead Sciences in Q3 2013 and held it in 24 quarters.
- Onex Canada Asset Management's Gilead Sciences position peaked at $27.8M in Q1 2014.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Onex Canada Asset Management's 13F filing for Q1 2024, filed 15 May 2024.